Navigation Links
Cell Therapeutics Decreases Net Loss for Nine Month Period in 2009 Compared to Same Period in 2008 by 45%
Date:11/5/2009

(799) Write-off of financing arrangement costs - - - (2,361) --- --- --- ------ Net loss before noncontrolling interest (35,077) (45,621) (68,223) (141,871) Noncontrolling interest 53 32 205 95 --- --- --- --- Net loss attributable to CTI (35,024) (45,589) (68,018) (141,776) Gain on restructuring of preferred stock - - 2,116 - Preferred stock dividends - (106) (24) (574) Deemed dividends on preferred stock (13,812) (1,951) (23,460) (19,216) ------- ------ ------- ------- Net loss attributable to CTI common shareholders $(48,836) $(47,646) $(89,386) $(161,566) ======== ======== ======== ========= Basic and diluted net loss per common share $(0.09) $(2.83) $(0.21) $(13.68) ====== ====== ====== ======= Shares used in calculation of basic and diluted net loss per common share 527,204 16,812 420,520 11,807 ======= ====== ======= ====== Balance Sheet Data: (amounts in thousands) September 30, December 31, 2009 2008 ---- ---- (unaudited) Cash and cash equivalents and securities available-for-sale $54,992 $10,671 Restricted cash - 6,640
'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Prime Therapeutics Receives TIPPS Certification
2. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
3. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
4. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
7. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
8. Prime Therapeutics Announces URAC Accreditation
9. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
10. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... September 03, 2015 , ... ... Haiti, has partnered with Slingshot® Product Development Group to manufacture a long-lasting reusable ... Michael Wahl with DriButts plans to bring 600 DriButts Diapers to rural areas ...
(Date:9/3/2015)... ... September 03, 2015 , ... Hope For The Warriors® ... 2016. Scholarships are awarded two times each year to spouses or caregivers of ... nonprofit dedicated to restoring a sense of self, restoring the family unit, and ...
(Date:9/3/2015)... ... 03, 2015 , ... Advice columnist, professional life coach and ... “Stop Wasting Your Time Blaming Others for Your Life.” , Released just in ... life’s obstacles by taking full responsibility for one’s life shares 15 important life ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... treatment for adults and adolescents struggling with anorexia, bulimia, binge eating disorder ... medical treatment team. As a Staff Psychiatrist, Dr. Calinoiu collaborates closely with ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... triggering cost increases for fully insured employer-sponsored health insurance plans, more employers are ... employees), according to data released from the 2014 United Benefit Advisors (UBA) Health ...
Breaking Medicine News(10 mins):Health News:DriButts Diapers Rely on Slingshot Help in Haiti 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 3Health News:Hope For The Warriors Spouse/Caregiver Scholarships Now Open for Spring 2016 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 3Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 2Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 4
... Dr. ... ... -- A recent study has found that post-menopausal women who underwent synthetic hormone replacement ... Danish women between the ages of 50 to 79 and resulted with scientists determining ...
... ... technology with the addition of the fractional carbon dioxide laser to extend suite of Lasers ... ... announced today that they have invested in new technology with the addition of a fractional ...
... CAPE TOWN, South Africa, July 21 Adverse economic ... to sub-Saharan Africa are posing major challenges to the medical ... and competition in these markets are expected to increase due ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ...
... ... that the U.S. Patent and Trademark Office has granted US Patent No. 7,547,413 to Bauer. ... disinfecting or sterilizing a surface, an object or an environment with a special treated water ... Waterloo, Ontario, Canada ...
... 21, 2009The individual health insurance market is not a viable ... from The Commonwealth Fund finds. Seventy-three percent of people who ... three years did not purchase a policy, primarily because premiums ... or who tried to buy coverage in the past three ...
... David Moher, from the Ottawa Hospital Research Institute; University ... the PRISMA guidelines: a set of tools developed to ... meta-analyses. In order to ensure wide distribution, the guidelines ... Annals of Internal Medicine , the BMJ , ...
Cached Medicine News:Health News:New Study Finds Yet Another Link to Cancer, Synthetic Hormones 2Health News:Fractional co2 Laser Offers Cosmetic Treatments with Minimal Downtime For Melbourne Patients 2Health News:Growth in African Medical Imaging Markets: Frost & Sullivan Examines the Potential 2Health News:Newly Patented Sterilization/Disinfection Method Reduces Risk of Microorganism Growth on Hard Surfaces 2Health News:Newly Patented Sterilization/Disinfection Method Reduces Risk of Microorganism Growth on Hard Surfaces 3Health News:New report: Individual health insurance market failing consumers 2Health News:New report: Individual health insurance market failing consumers 3Health News:New report: Individual health insurance market failing consumers 4
(Date:9/3/2015)... Sep. 03, 2015 Research ... of the "Investigation Report on China,s Raloxifene Market, ... to the statistics, over 200 million people suffer from ... above in China , 50% have ... 30%-50% among women aged 60 and above. Raloxifene ...
(Date:9/3/2015)... -- China,s startup business ExtantFuture ... wearable medical device that can continuously monitor the fetal ... guidance for pregnant women. The device will debut on ... measures 4 centimeters in diameter, is as thin as ... an Apple earphone cord. The small and compact device ...
(Date:9/3/2015)... Sept. 3, 2015 HeartWare International, Inc ... less invasive, miniaturized circulatory support technologies that are revolutionizing ... its President and Chief Executive Officer, Doug Godshall ... Fargo Healthcare Conference at 8:50 a.m. ET on Wednesday, ... 2015 at The Hyatt Regency, Boston ...
Breaking Medicine Technology:Investigation Report on China's Raloxifene Market, 2015-2019 2Modoo to Debut at Kickstarter: First Device on the Market that Enables Continuous Monitoring of Fetal Heart Rate and Fetal Movement 2HeartWare Presentation At The 2015 Wells Fargo Healthcare Conference To Be Webcast 2
... 28 Parents may be giving their children ... research being presented this week at Research Forum ... American College of Emergency Physicians.  Two studies are ... Medication Dosing Cups Are Inaccurate" and "Do Parents ...
... YORK, Sept. 27 Pfizer Inc. announced today ... trial evaluating SUTENT® (sunitinib malate) in combination with ... (CRPC) that had progressed despite treatment with a ... an independent Data Monitoring Committee (DMC) found that ...
Cached Medicine Technology:Warnings Re: Over-the-Counter Medication for Children: Less is More 2Pfizer Discontinues Phase 3 Trial of SUTENT® in Advanced Castration-Resistant Prostate Cancer 2Pfizer Discontinues Phase 3 Trial of SUTENT® in Advanced Castration-Resistant Prostate Cancer 3Pfizer Discontinues Phase 3 Trial of SUTENT® in Advanced Castration-Resistant Prostate Cancer 4
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Severe revision options for the knee and hip...
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
Medicine Products: